Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 50,733 |
|
|||||
| News | - | ||||||
| Day High | 1.73 | Low High |
|||||
| Day Low | 1.56 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Biofrontera Inc | BFRI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.10 | -5.92% | 1.59 | 23:00:08 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.66 | 1.56 | 1.73 | 1.59 | 1.69 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 276 | 50,733 | US$ 1.62 | US$ 82,176 | - | 0.61 - 13.42 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:34:51 | formt | 235 | US$ 1.59 | USD |
Biofrontera Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.41M | 1.52M | - | 34.07M | -20.13M | -13.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biofrontera News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/08/2024 | 16:14 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 3/05/2024 | 16:20 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
| 2/23/2024 | 08:26 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/20/2024 | 08:37 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/20/2024 | 06:55 | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request |
| 2/05/2024 | 16:25 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/02/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/25/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/11/2024 | 15:40 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/09/2024 | 16:01 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 1/03/2024 | 16:27 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/28/2023 | 16:25 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BFRI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.71 | 1.7861 | 1.376 | 1.57 | 60,389 | -0.12 | -7.02% |
| 1 Month | 1.57 | 2.4302 | 1.376 | 1.88 | 128,744 | 0.02 | 1.27% |
| 3 Months | 1.24 | 2.4302 | 0.61 | 1.12 | 843,644 | 0.35 | 28.23% |
| 6 Months | 4.17 | 5.28 | 0.61 | 1.23 | 416,662 | -2.58 | -61.87% |
| 1 Year | 11.438 | 13.42 | 0.61 | 3.19 | 271,772 | -9.85 | -86.10% |
| 3 Years | 81.80 | 292.60 | 0.61 | 121.52 | 2,243,492 | -80.21 | -98.06% |
| 5 Years | 81.80 | 292.60 | 0.61 | 121.52 | 2,243,492 | -80.21 | -98.06% |
Biofrontera Description
| Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection. |
